Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue

Journal of Virology

Volumn 79, Issue 5, 2005, Pages 3117-3126

  Gillgrass, Amy E ^a   Tang, Vera A ^a   Towarnicki, Kate M ^a   Rosenthal, Kenneth L ^a   Kaushic, Charu ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; ESTRADIOL; GLYCOPROTEIN P 15095; HERPES VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LIVE VACCINE; PROGESTERONE; SEX HORMONE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INFECTION SENSITIVITY; LAMINA PROPRIA; LYMPHOID TISSUE; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; T LYMPHOCYTE ACTIVATION; VAGINA ASSOCIATED LYMPHOID TISSUE; VAGINA MUCOSA; VAGINA SECRETION; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS TITRATION;

ANIMALS; ANTIBODIES, VIRAL; ESTRADIOL; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; LYMPHOID TISSUE; MICE; MICE, INBRED C57BL; MUTATION; PROGESTERONE; T-LYMPHOCYTES; VACCINES, ATTENUATED; VAGINA; VIRAL VACCINES;

ANIMALIA; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 2;

EID: 13944258420     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.5.3117-3126.2005     Document Type: Article

References (39)

1. Abel, K., T. Rourke, D. Lu, K. Bost, M. B. McChesney, and C. J. Miller. 2004. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with simian immunodeficiency virus mac239. J. Infect. Dis. 190:1697-1705.
2. Aral, S. O., and K. K. Holmes. 1999. Social and behavioral determinants of the epidemiology of STDs: industrialized and developing countries, p. 95-106. In K. K. Holmes, P. F. Sparling, P. A. Mardh, S. M. Lemon, et al. (ed.), Sexually transmitted diseases, 3rd ed. McGraw-Hill, New York, N.Y.
3. Beagley, K. W., and C. M. Gockel. 2003. Regulation of innate and adaptive immunity by female sex hormones oestradiol and progesterone. FEMS Immunol. Med. Microbiol. 38:13-22.
4. Benki, S., S. B. Mostad, B. A. Richardson, K. Mandaliya, J. K. Kreiss, and J. Overbaugh. 2004. Cyclic shedding of HIV-1 RNA in cervical secretions during the menstrual cycle. J. Infect. Dis. 189:2192-2201.
5. Crowley, T., P. Borner, A. Hughes, J. Berry, I. Paul, and O. Caul. 1997. Hormonal factors and laboratory detection of Chlamydia trachomatis in women: implications for screening? Int. J. STD AIDS 8:25-31.
6. Gallichan, W. S., T. Gurasachi, and K. L. Rosenthal. 2001. Intranasal immunization with CpG oligonucleotides as an adjuvant dramatically increases IgA and protection against HSV-2 in the genital tract. J. Immunol. 166:3451-3457.
7. Gallichan, W. S., and K. L. Rosenthal. 1996. Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunization. J. Exp. Med. 184:1879-1890.
8. Gallichan, W. S., and K. L. Rosenthal. 1998. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 177:1155-1161.
9. Gillgrass, A. E., A. A. Ashkar, K. L. Rosenthal, and C. Kaushic. 2003. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 77:9845-9851.
10. 9a. Gillgrass, A. E., S. A. Fernandez, K. L. Rosenthal, and C. Kaushic. 2005. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation. J. Virol. 79:3107-3116.
11. Harandi, A. M., B. Svennerholm, J. Holmgren, and K. Eriksson. 2001. Protective vaccination against genital herpes simplex virus, type 2 infection in mice is associated with a rapid induction of local IFN-gamma-dependent-RANTES production following a vaginal viral challenge. Am. J. Reprod. Immunol. 46:420-424.
12. Katzenellenbogen, B. S. 2000. Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. J. Soc. Gynecol. Investig. 7:S33-S37.
13. Kaushic, C., A. A. Ashkar, L. A. Reid, and K. L. Rosenthal. 2003. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J. Virol. 77:4558-4565.
14. Kaushic, C., E. Frauendorf, and C. R. Wira. 1997. Polymeric immunoglobulin A receptor in the rodent female reproductive tract: influence of estradiol in the vagina and differential expression of messenger ribonucleic acid during estrous cycle. Biol. Reprod. 57:958-966.
15. Kaushic, C., A. D. Murdin, B. J. Underdown, and C. R. Wira. 1998. Chlamydia trachomatis infection in the female reproductive tract of the rat: influence of progesterone on infectivity and immune response. Infect. Immun. 66:893-898.
16. Kaushic, C., F. Zhou, A. D. Murdin, and C. R. Wira. 2000. Effect of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect. Immun. 68: 4207-4216.
17. Koelle, D. M., and L. Corey. 2003. Recent progress in herpes simplex virus immunobiology and vaccine research. Clin. Microbiol. Rev. 16:96-113.
18. Kuhn, L., L. Denny, A. E. Pollack, and T. C. Wright. 1999. Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception 59:363-367.
19. Kuklin, N. A., M. Daheshia, S. Chun, and B. T. Rouse. 1998. Role of mucosal immunity in herpes simplex virus infection. J. Immunol. 160:5998-6003.
20. Kwant, A., and K. L. Rosenthal. 2004. Intravaginal immunization with a viral subunit protein plus CpG oligonucleotides induces protective immunity against HSV-2. Vaccine 22:23-24.
21. Martin, H. L., Jr., P. M. Nyange, B. A. Richardson, L. Lavreys, K. Mandaliya, D. J. Jackson, J. O. Ndinya-Achola, and J. Kreiss. 1998. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 178:1053-1059.
22. Marx, P. A., A. I. Spira, A. Gettie, et al. 1996. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat. Med. 2:1084-1089.
23. McDermott, M. R., L. J. Brais, and M. J. Evelegh. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71:1497-1504.
24. McDermott, M. R., C. H. Goldsmith, K. L. Rosenthal, and L. J. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:460-466.
25. McDermott, M. R., B. J. Smiley, L. J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:747-753.
26. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-268.
27. Milligan, G. N., D. I. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosa and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160: 6093-6100.
28. Moyron-Quiroz, J. E., J. Rangel-Moreno, K. Kusser, L. Hartson, F. Sprague, S. Goodrich, D. L. Woodland, F. E. Lund, and T. D. Randall. 2004. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 10:927-934.
29. Nohmi, T., S. Abe, K. Dobashi, S. Tansho, and H. Yamaguchi. 1995. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal candidiasis. Microbiol. Immunol. 39:405-409.
30. Parr, E. L., and M. B. Parr. 1999. Immune responses and protection against vaginal infection after nasal or vaginal immunization with attenuated herpes simplex virus type-2. Immunology 98:639-645.
31. Parr, M. B., and E. L. Parr. 2003. Vaginal immunity in the HSV-2 mouse model. Int. Rev. Immunol. 22:43-63.
32. Sonnex, G. 1998. Influence of ovarian hormones on urogenital infection. Sex. Transm. Infect. 74:11-19.
33. Stanberry, L. R., S. L. Spruance, A. L. Cunningham, D. L. Bernstein, A. Mindel, S. Sacks, S. Tyring, F. Y. Aoki, M. Sloui, M. Denis, P. Vandepapeliere, G. Dubin, and the GlaxoSmithKline Herpes Vaccine Efficacy Study Group. 2002. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N. Engl. J. Med. 347:1652-1661.
34. Tibbetts, T. A., O. M. Conneely, and B. W. O'Malley. 1999. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol. Reprod. 60:1158-1165.
35. Wang, C. C., R. S. McClelland, J. Overbaugh, M. Reilly, D. D. Panteleeff, K. Mandaliya, B. Chohan, L. Lavreys, J. Ndinya-Achola, and J. K. Kreiss. 2004. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18:205-209.
36. Wira, C. R., and C. Kaushic. 1996. Mucosal immunity in the female reproductive tract: effect of sex hormones on immune recognition and responses, p. 375-386. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines: new trends in immunization. Academic Press, New York, N. Y.
37. Wira, C. R., C. Kaushic, and J. Richardson. 1999. Role of sex hormones and cytokines in regulating mucosal immune system in the female reproductive tract, p. 1449-1461. In P. L. Ogra, J. Mestecky, et al. (ed.), Mucosal immunology. Academic Press, New York, N.Y.
38. Wira, C. R., and R. M. Rossoll. 1995. Antigen presenting cells in the female reproductive tract: influence of estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 136:4526-4534.
39. Yang, X. 2003. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9:67-73.